SUPERSTRING CAPITAL MANAGEMENT LP

CIK 0001931118 · NEW YORK, NY · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

SUPERSTRING CAPITAL MANAGEMENT LP reported 32 positions worth $158.4M as of June 30, 2026 (13F filed August 14, 2026). Largest holding: COGT (8.4%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$158.4M
2026 Q2
Positions
32
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
63.8%
Est. Net Flow (Q)
2026 Q2
10 / 32 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1COGTCOGENT BIOSCIENCES INCSH$13.3M8.39%343,284
2AXSMAXSOME THERAPEUTICS INC.SH$13.2M8.33%53,916
3GMABGENMAB A/SSH$11.8M7.47%430,600
4CLDXCELLDEX THERAPEUTICS INC NEWSH$10.7M6.76%287,583
5TRVITREVI THERAPEUTICS INCSH$9.8M6.17%524,224
6RVMDREVOLUTION MEDICINES INCSH$9.6M6.04%51,053
7DFTXDEFINIUM THERAPEUTICS INCSH$8.9M5.59%188,282
8VIRVIR BIOTECHNOLOGY INCSH$8.7M5.49%853,685
9IMVTIMMUNOVANT INCSH$8.0M5.07%208,368
10URGNUROGEN PHARMA LTDSH$7.0M4.45%191,313

The free plan shows the top 10 positions. The remaining 22 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does SUPERSTRING CAPITAL MANAGEMENT LP hold as of Q2 2026?

SUPERSTRING CAPITAL MANAGEMENT LP reported 32 positions worth $158.4M in its Q2 2026 13F filing. Largest positions: COGT (8.4%), AXSM (8.3%), GMAB (7.5%), CLDX (6.8%) and TRVI (6.2%).

What did SUPERSTRING CAPITAL MANAGEMENT LP buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did SUPERSTRING CAPITAL MANAGEMENT LP sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.